You have no items in your shopping cart.
On Promotion
Species Host
Tested Applications
Predicted Reactivity
Conjugation
Featured Product
Search results for: 'JAK1'
SAR-20347 [orb1226248]>98% (HPLC)
1450881-55-6
444.847
C21H18ClFN4O4
1 g, 500 mg, 5 mg, 10 mg, 25 mg, 50 mg, 100 mg, 2 mg- JAK3-IN-2 [orb1226269]
>98% (HPLC)
1443235-95-7
350.378
C19H18N4O3
1 g, 500 mg, 200 mg, 10 mg, 50 mg, 5 mg, 25 mg, 100 mg, 2 mg - GLPG0634 analogue [orb1223391]
>98% (HPLC)
1206101-20-3
425.5
C21H23N5O3S
1 g, 100 mg, 50 mg, 2 mg, 25 mg, 5 mg, 10 mg, 500 mg - XL019 [orb1223549]
>98% (HPLC)
945755-56-6
444.53
C25H28N6O2
1 g, 500 mg, 200 mg, 10 mg, 50 mg, 100 mg, 5 mg, 25 mg - Peficitinib [orb1223560]
>98% (HPLC)
944118-01-8
326.3929
C18H22N4O2
500 mg, 200 mg, 5 mg, 50 mg, 100 mg, 10 mg, 1 g - Ruxolitinib S enantiomer [orb1223574]
>98% (HPLC)
941685-37-6
306.365
C17H18N6
1 g, 500 mg, 200 mg, 50 mg, 100 mg, 5 mg, 10 mg - Pacritinib [orb1223586]
>98% (HPLC)
937272-79-2
472.58
C28H32N4O3
5 mg, 10 mg, 25 mg, 2 mg, 1 g, 500 mg, 50 mg, 100 mg - TG-101348 [orb1223595]
>98% (HPLC)
936091-26-8
524.6782
C27H36N6O3S
500 mg, 100 mg, 5 mg, 10 mg, 200 mg, 50 mg, 1 g - Tofacitinib citrate [orb1224747]
>98% (HPLC)
540737-29-9
504.4931
C22H28N6O8
1 g, 5 mg, 500 mg, 10 mg, 200 mg, 50 mg, 100 mg - Mubritinib [orb1222320]
>98% (HPLC)
366017-09-6
468.47
C25H23F3N4O2
1 g, 500 mg, 10 mg, 200 mg, 25 mg, 50 mg, 100 mg